SAN FRANCISCO, Feb. 6, 2019 /PRNewswire/ -- NXM Labs Inc., an autonomous security and data integrity company headquartered in San Francisco with R&D facilities in Toronto, today announced the close of its pre-Series A US funding to commercialize its award-winning NXM SecureSuite software platform Read more...
DALLAS, May 15, 2019 /PRNewswire/ -- New Parks Associates research finds recommendations from friends and family and online review Read more...
OKLAHOMA CITY, June 14, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics announced that it has received a notification letter and an Establishment Inspection Reports (EIRs) from the U.S. Food and Drug Administration (FDA) for its Oklahoma City site, FEI registration numbers: 3006341547. The notification and the EIR are to close, under 21 CFR 20.64(d)(3), a Pre-Approval Read more...
